Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Autor: Eertink, J. J., Zwezerijnen, G. J. C., Heymans, M. W., Pieplenbosch, S., Wiegers, S. E., Dührsen, U., Hüttmann, A., Kurch, L., Hanoun, C., Lugtenburg, P. J., Barrington, S. F., Mikhaeel, N. G., Ceriani, L., Zucca, E., Czibor, S., Györke, T., Chamuleau, M. E. D., Hoekstra, O. S., de Vet, H. C. W., Boellaard, R., Zijlstra, J. M.

Publikováno v: In Blood 22 June 2023 141(25):3055-3064

Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP

Autor: Driessen, J., Kersten, M. J., Visser, L., van den Berg, A., Tonino, S. H., Zijlstra, J. M., Lugtenburg, P. J., Morschhauser, Franck, Hutchings, M., Amorim, S., Gastinne, T., Nijland, M., Zwezerijnen, G. J. C., Boellaard, R., de Vet, H. C. W., Arens, A. I. J., Valkema, R., Liu, R. D. K., Drees, E. E. E., de Jong, D., Plattel, W. J., Diepstra, A.

Publikováno v: Leukemia
Leukemia, 2022, Leukemia, 36, pp.2853-2862. ⟨10.1038/s41375-022-01717-8⟩
Leukemia, 36, 2853-2862
Leukemia, 36(12), 2853-2862. Nature Publishing Group
Leukemia, 36, 12, pp. 2853-2862
Leukemia, 36. Nature Publishing Group
On behalf of the HOVON Lunenburg Lymphoma Phase I/II Consortium (LLPC) 2022, ' Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP ', Leukemia, vol. 36, no. 12, pp. 2853-2862 . https://doi.org/10.1038/s41375-022-01717-8

Contains fulltext : 287833.pdf (Publisher’s version ) (Closed access) Risk-stratified treatment strategies have the potential to increase survival and lower toxicity in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) patients. This study i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e50f6bae412ba40b0fec7bfc0be6382
https://hal.univ-lille.fr/hal-04144417

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MACROPHAGE PET/CT IMAGING OF THE FEET CAN CONTRIBUTE TO EARLY PREDICTION OF THERAPY OUTCOME IN RHEUMATOID ARTHRITIS

Autor: Verweij, N. J. F., Ter Wee, M., De Jongh, J., Zwezerijnen, G. C. J., Yaqub, M., Van Schaardenburg, D., Voskuyl, A., Lems, W., Lammertsma, A. A., Boers, M., Van der Laken, C. J.

Publikováno v: Annals of the Rheumatic Diseases, 80, 114-114. BMJ Publishing Group
Verweij, N J F, Ter Wee, M, De Jongh, J, Zwezerijnen, G C J, Yaqub, M, Van Schaardenburg, D, Voskuyl, A, Lems, W, Lammertsma, A A, Boers, M & Van der Laken, C J 2021, ' MACROPHAGE PET/CT IMAGING OF THE FEET CAN CONTRIBUTE TO EARLY PREDICTION OF THERAPY OUTCOME IN RHEUMATOID ARTHRITIS ', Annals of the Rheumatic Diseases, vol. 80, pp. 114-114 . https://doi.org/10.1136/annrheumdis-2021-eular.2189

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5bae223293a7643be3c2d3f20d04a567
https://research.vumc.nl/en/publications/1f2b0404-805f-4798-8ead-b2d344248c39

F-18-FDG PET/CT baseline radiomics features are predictive of outcome in diffuse large B-cell lymphoma patients

Autor: Eertink, J., van de Brug, T., Wiegers, S. E., Zwezerijnen, G. J. C., Pfaehler, E., Lugtenburg, P. J., van der Holt, B., de Vet, H. C. W., Hoekstra, O. S., Boellaard, R., Zijlstra, J. M.

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, 47(SUPPL 1), S125-S125. Springer Verlag
Eertink, J, van de Brug, T, Wiegers, S E, Zwezerijnen, G J C, Pfaehler, E, Lugtenburg, P J, van der Holt, B, de Vet, H C W, Hoekstra, O S, Boellaard, R & Zijlstra, J M 2020, ' F-18-FDG PET/CT baseline radiomics features are predictive of outcome in diffuse large B-cell lymphoma patients ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. SUPPL 1, pp. S125-S125 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::951aaae5df1d42771291a89cca2f3824
https://research.vumc.nl/en/publications/d2e9d41f-edbb-4a4e-a8b0-b521f8dfc627